Pharma stocks underperformed during Trump's first term. Will second term change the narrative?
During Trumps 2017-2021 tenure, Indian pharma equities faced challenges, including increased FDA regulatory actions that ...
Trump rolls back effort to lower Medicare, Medicaid drug costs
President Donald Trump, in signing dozens of executive orders on Monday, rescinded an effort by former President Joe Biden to lower drug costs by directing Medicare and Medicaid to test models that ...
ohiocapitaljournal52m
Reproductive rights and justice groups plan for Trump’s return
Reproductive rights activists are focused on how to maintain and expand access to abortion and birth control but also ...
Alternative medicine fans see RFK Jr. as a hero. The field’s skeptics worry.
Kennedy’s potential ascent as HHS secretary brings promise for backers of alternative-health approaches, while skeptics say ...
thecooldown1h
Startup uses cutting-edge tech to turn microscopic organisms into food source of the future: 'Enough protein for the world'
The global food system contributes up to 35% of all climate-warming pollution. LanzaTech's microbe-based protein could be a ...
A woman regained weight after she stopped taking semaglutide. Now she works 2 jobs to afford it.
A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...
Yakima Herald-Republic2hOpinion
Column: Trump nominees pose danger to Americans’ health
Donald Trump’s more controversial personnel choices have prompted fears that Tulsi Gabbard would compromise intelligence ...
Hosted on MSN2h
Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...
Trump administration directs federal health agencies to pause communications
Amid a deluge of executive actions, the Trump administration has asked federal health agencies to pause external ...
Food Safety News6h
Outgoing FDA Commissioner Robert Califf discusses agency’s uncertain future
Dr. Robert M. Califf bid farewell to his role as Commissioner of the U.S. Food and Drug Administration in a reflective post ...
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
wusf7h
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...